OAC
LEGN icon

OMERS Administration Corp’s Legend Biotech LEGN Stock Holding History

OMERS Administration Corp’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-40,400
Closed -$1.37M – 1007
2025
Q1 		$1.37M Buy
+40,400
New +$1.45M 0.01% 496

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

OMERS Administration Corp's LEGN Position: Q2 2025 in Review

OMERS Administration Corp sold out of Legend Biotech (LEGN) in Q2 2025, closing a stake of 40,400 shares — an estimated $1.37M sold.

OMERS Administration Corp first reported a position in LEGN in Q1 2025 and held it in 1 quarter. The position peaked at $1.37M in Q1 2025. 210 funds tracked by Wall St. Rank hold LEGN as of Q2 2025.

  • OMERS Administration Corp reported no remaining Legend Biotech position as of Q2 2025 after selling out during the quarter.
  • OMERS Administration Corp sold 40,400 Legend Biotech shares in Q2 2025, an estimated $1.37M.
  • OMERS Administration Corp first reported a position in Legend Biotech in Q1 2025 and held it in 1 quarter.
  • OMERS Administration Corp's Legend Biotech position peaked at $1.37M in Q1 2025.
  • 210 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2025.

Based on OMERS Administration Corp's 13F filing for Q2 2025, filed 13 Aug 2025.